Cargando…

Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study

OBJECTIVES: Myelodysplastic syndrome (MDS) is a heterogeneous hematopoietic stem cell disorder with thrombocytopenia. Flow cytometric immunophenotyping of blood cells has been instrumental in diagnosis as co-criteria, but the data regarding platelets remains lacking. This study aims to determine if...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yi-Feng, Gu, Ming-Huei, Liu, Chao-Zong, Huang, Wei-Han, Chu, Sung-Chao, Wang, Tso-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678267/ https://www.ncbi.nlm.nih.gov/pubmed/36409726 http://dx.doi.org/10.1371/journal.pone.0278040

Ejemplares similares

Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance
por: Li, Lijuan, et al.
Publicado: (2022)

Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe Thrombocytopenia
por: Tang, Yaqiong, et al.
Publicado: (2018)

Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor–mutated lung adenocarcinoma
por: Li, Chi-Cheng, et al.
Publicado: (2020)

Mean platelet component and mean platelet volume as useful screening markers for myelodysplastic syndrome
por: Masutani, Ryota, et al.
Publicado: (2018)

Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes
por: Chen, Qiuni, et al.
Publicado: (2022)

Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia
por: Shen, Chih-Lung, et al.
Publicado: (2022)

Medich Giant Platelet Syndrome: An Evolving Qualitative and Quantitative Platelet Disorder
por: Massey, Gita, et al.
Publicado: (2022)

Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome
por: Corrao, Kristen, et al.
Publicado: (2022)

Myeloblasts transition to megakaryoblastic immunophenotypes over time in some patients with myelodysplastic syndromes
por: Ogata, Kiyoyuki, et al.
Publicado: (2023)

Determination in vivo viability of a transfused platelet product by corrected count increment and percentage platelet response
por: Thuku, Nancy Wanjiru, et al.
Publicado: (2017)

Platelet Markers Correlate with Glycemic Indices in Diabetic, but Not Diabetic-Myelodysplastic Patients with Normal Platelet Count
por: Dalamaga, Maria, et al.
Publicado: (2010)

An Elevated Percentage of Reticulated Platelet Is Associated With Increased Mortality in Septic Shock Patients
por: Wu, Qin, et al.
Publicado: (2015)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes
por: Ganan-Gomez, Irene, et al.
Publicado: (2022)

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
por: van Spronsen, Margot F., et al.
Publicado: (2023)

Examination of the Percentage of Immature Platelet Fraction in Term and Preterm Infants at Birth
por: Yuko, Sakurai, et al.
Publicado: (2013)

Platelet to Lymphocyte Percentage Ratio Is Associated With Brachial–Ankle Pulse Wave Velocity in Hemodialysis
por: Chen, Szu-Chia, et al.
Publicado: (2016)

Platelet abnormalities in Huntington’s disease
por: Denis, Hélèna L, et al.
Publicado: (2019)

Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores
por: Reis-Alves, Suiellen C., et al.
Publicado: (2013)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
por: Zahid, Mohammad Faizan, et al.
Publicado: (2017)

Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial
por: Platzbecker, U, et al.
Publicado: (2014)

Correlation of percentage changes in platelet counts with recurrence rate following radical nephrectomy
por: Patel, A., et al.
Publicado: (2010)

A simple score derived from bone marrow immunophenotyping is important for prognostic evaluation in myelodysplastic syndromes
por: Vido-Marques, J. R., et al.
Publicado: (2020)

PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
por: Trubkina, Hanna, et al.
Publicado: (2023)

Correction: Platelet abnormalities in Huntington’s disease
Publicado: (2019)

Platelet Activation and Cytokine Release of Interleukin-8 and Interferon-Gamma-Induced Protein 10 after ChAdOx1 nCoV-19 Coronavirus Vaccine Injection
por: Shen, Chih-Lung, et al.
Publicado: (2023)

Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients
por: Jung, Hyun Ae, et al.
Publicado: (2015)

Lobectomy for lung cancer in a myelodysplastic syndrome patient with decreasing platelet aggregation: report of a case
por: Koezuka, Satoshi, et al.
Publicado: (2018)

Abnormal Macrophage Polarization in Patients with Myelodysplastic Syndrome
por: Zhang, Gaochao, et al.
Publicado: (2021)

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
por: Divoux, Marion, et al.
Publicado: (2020)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Durand, Pauline, et al.
Publicado: (2023)

Haemorrhagic Disorders Due to Functional Abnormalities of Platelets
por: Hardisty, R. M.
Publicado: (1969)

Thrombin generation abnormalities in Quebec platelet disorder
por: Brunet, Justin G., et al.
Publicado: (2020)

Abnormal platelet aggregation in pediatric pulmonary hypertension
por: Handler, Stephanie S., et al.
Publicado: (2022)

Platelet Abnormalities in Children with Laboratory-Confirmed Influenza
por: Wrotek, August, et al.
Publicado: (2023)

Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes
por: Zhang, Wei, et al.
Publicado: (2018)

Recombinant Human Thrombopoietin Accelerates the Recovery of Platelet in Patients With Lower-Risk Myelodysplastic Syndrome: A Proof-of-Concept Study
por: Yang, Yuan, et al.
Publicado: (2021)

Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+ Blasts and Its Clinical Significance for Myelodysplastic Syndromes
por: Xu, Feng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i4gokm7vuf2qq0s3u5t15s70t3